Expansion of human SCID-repopulating cells under hypoxic conditions

被引:272
作者
Danet, GH
Pan, Y
Luongo, JL
Bonnet, DA
Simon, MC
机构
[1] Univ Penn, Sch Med, Div Hematol Oncol, Philadelphia, PA 19104 USA
[2] Univ Penn, Ctr Canc, Howard Hughes Med Inst, Philadelphia, PA 19104 USA
[3] Univ Penn, Ctr Canc, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA
[4] Canc Res UK, London Res Inst, London, England
关键词
D O I
10.1172/JCI200317669
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 [基础医学];
摘要
It has been proposed that bone marrow (BM) hematopoietic stem and progenitor cells are distributed along an oxygen (O-2) gradient, where stem cells reside in the most hypoxic areas and proliferating progenitors are found in O-2-rich areas. However, the effects of hypoxia on human hematopoietic stem cells (HSCs) have not been characterized. Our objective was to evaluate the functional and molecular responses of human BM progenitors and stem cells to hypoxic conditions. BM lineage-negative (Lin-) CD34(+)CD38(-) cells were cultured in serum-free medium under 1.5% O-2 (hypoxia) or 20% O-2 (normoxia) for 4 days. Using limiting dilution analysis, we demonstrate that the absolute number of SCID-repopulating cells (SRCs) increased by 5.8-fold in hypoxic cultures compared with normoxia, and by 4.2-fold compared with freshly isolated Lin(-)CD34(+)CD38(-) cells. The observed increase in BM-repopulating activity was associated with a preferential expansion of Lin(-)CD34(+)CD38(-) cells. We also demonstrate that, in response to hypoxia, hypoxia-inducible factor-1alpha. protein was stabilized, surface expression of angiogenic receptors was upregulated, and VEGF secretion increased in BM Lin(-)CD34(+) cultures. The use of low O2 levels to enhance the survival and/or self-renewal of human BM HSCs in vitro represents an important advance and could have valuable clinical implications.
引用
收藏
页码:126 / 135
页数:10
相关论文
共 64 条
[1]
Multilineage embryonic hematopoiesis requires hypoxic ARNT activity [J].
Adelman, DM ;
Maltepe, E ;
Simon, MC .
GENES & DEVELOPMENT, 1999, 13 (19) :2478-2483
[2]
Bone morphogenetic proteins regulate the developmental program of human hematopoietic stem cells [J].
Bhatia, M ;
Bonnet, D ;
Wu, DM ;
Murdoch, B ;
Wrana, J ;
Gallacher, L ;
Dick, JE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (07) :1139-1147
[3]
Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture [J].
Bhatia, M ;
Bonnet, D ;
Kapp, U ;
Wang, JCY ;
Murdoch, B ;
Dick, JE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (04) :619-624
[4]
Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice [J].
Bhatia, M ;
Wang, JCY ;
Kapp, U ;
Bonnet, D ;
Dick, JE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (10) :5320-5325
[5]
Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice [J].
Bonnet, D ;
Bhatia, M ;
Wang, JCY ;
Kapp, U ;
Dick, JE .
BONE MARROW TRANSPLANTATION, 1999, 23 (03) :203-209
[6]
Interleukin-3 supports expansion of long-term multilineage repopulating activity after multiple stem cell divisions in vitro [J].
Bryder, D ;
Jacobsen, SEW .
BLOOD, 2000, 96 (05) :1748-1755
[7]
Ex vivo culture with human brain endothelial cells increases the SCID-repopulating capacity of adult human bone marrow [J].
Chute, JP ;
Saini, AA ;
Chute, DJ ;
Wells, MR ;
Clark, WB ;
Harlan, DM ;
Park, J ;
Stull, MK ;
Civin, C ;
Davis, TA .
BLOOD, 2002, 100 (13) :4433-4439
[8]
CIPOLLESCHI MG, 1993, BLOOD, V82, P2031
[9]
Cipolleschi MG, 1997, EXP HEMATOL, V25, P1187
[10]
Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein [J].
Cockman, ME ;
Masson, N ;
Mole, DR ;
Jaakkola, P ;
Chang, GW ;
Clifford, SC ;
Maher, ER ;
Pugh, CW ;
Ratcliffe, PJ ;
Maxwell, PH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (33) :25733-25741